Clinical Trials on Gender Dysphoria, Adolescent in Belgium

Total 51 results

University Ghent

Recruiting

Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People

Gender Dysphoria

Belgium
University Hospital, Ghent

Recruiting

Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery (PROGAS)

Gender Dysphoria

Belgium
University Hospital, Ghent

Recruiting

A European Network for the Investigation of Gender Incongruence (ENIGI)

Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons

Belgium, Italy, Netherlands, Norway
University Hospital, Ghent

Recruiting

ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery

Gender Dysphoria | Erectile Dysfunction

Belgium
Brugmann University Hospital

Completed

Gender Influence on Morbi-mortality in Pediatric Cardiac Surgery.

Pediatric Cardiac Surgery | Gender

Belgium
University Ghent

Completed

Effectiveness of Speech Therapy in Trans Women.

Gender Dysphoria | Speech Therapy | Transgenderism | Voice Disorder Due to Transsexualism

Belgium
University Hospital, Ghent
ELATOR/EREKTOR

Recruiting

Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. (EROS)

Sexual Dysfunction | Gender Dysphoria | Erectile Dysfunction | Prosthesis Durability | Transgenderism

Belgium, Netherlands
Universitaire Ziekenhuizen KU Leuven
Jessa Hospital; Algemeen Ziekenhuis Maria Middelares

Completed

Screening and Diagnosing Exercise-induced Bronchoconstriction in Recreational Young Athletes (12-18 y)

Adolescent | Biomarker | Exercise Induced Bronchoconstriction | Young Athletes

Belgium
Universitaire Ziekenhuizen KU Leuven

Enrolling by invitation

3D, Dynamic and Mechanically-informed Decision Making in AIS (3D-AIS)

Adolescent Idiopathic Scoliosis

Belgium
Hasselt University
Jessa Hospital

Completed

Chronotropic Incompetence During Exercise in Obese Adolescents: Clinical Implications and Pathophysiology (CICO)

Obesity | Adolescent Obesity

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Buspirone for Weak or Absent Esophageal Peristalsis

Dysphagia, Esophageal

Belgium
University Hospital, Ghent
Groupe SEBBIN

Recruiting

Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants

Gender Dysphoria | Orchitis | Testicular Cancer | Prosthesis Durability | Testicular Torsion | Undescended Testes | Testicular Agenesis | Testicular Atrophy

Belgium
Queen Fabiola Children's University Hospital

Not yet recruiting

Registry on Obesity Surgery in Adolescents (ROSA)

Morbid Obesity | Adolescent Obesity | Bariatric Surgery

Belgium
Queen Fabiola Children's University Hospital
Brugmann University Hospital; Erasme University Hospital; Université Libre de... and other collaborators

Recruiting

Psychiatry of Transition in a World in Transition (Transition_psy)

Mental Health | Mental Disorder in Adolescence | Transitional Care

Belgium
University Ghent
University of Utah; Universiteit Antwerpen

Recruiting

Autonomic Dysfunction in Functional Dysphonia

Muscle Tension Dysphonia | Functional Voice Disorder | Psychogenic Voice Disorder

Belgium
University Ghent
Research Foundation Flanders

Completed

Move it, Move ID! Promotion of Physical Activity in Adolescents With Intellectual Disability

Physical Activity | Intellectual Disability | Health Promotion | Adolescents

Belgium
Universitaire Ziekenhuizen KU Leuven
Phagenesis Ltd.

Recruiting

The Effect of Pharyngeal Electrical Stimulation on Peripheral Biomechanical Aspects of Deglutition (PES)

Dysphagia | Dysphagia Following Cerebrovascular Accident

Belgium
Eli Lilly and Company

Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer (CAMPFIRE)

Adolescent | Neoplasms | Child

United States, Spain, United Kingdom, Australia, Italy, Japan, Belgium, France, Germany
Cliniques universitaires Saint-Luc- Université...

Completed

Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases

Neuromuscular Diseases | Dysphagia

Belgium
Janssen Research & Development, LLC

Completed

A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants

Healthy

Belgium
University Hospital, Ghent

Terminated

Nitrous Oxide - Sevoflurane-Remifentanil Interaction

ASA Class I/II Patients Scheduled for Surgery Under General Anesthesia

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Research Foundation Flanders

Completed

Sleep IntervEntion as Symptom Treatment for ADHD (SIESTA)

Sleep | ADHD | CBT | Adolescents

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Diagnosis of EIB in Young Elite Athletes (13-18 y)

Adolescent | Athletes | Exercise Induced Bronchospasm

Belgium
Janssen R&D Ireland

Completed

A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

Healthy Participants

Belgium
University Hospital, Ghent
Universiteit Antwerpen

Completed

Evaluation of Transition With a Heart, a Transition Program for Adolescents With Congenital Heart Disease and Parents

Transitional Care | Congenital Heart Disease in Adolescence

Belgium
University Hospital, Ghent

Completed

Effect of Semi-occluded Vocal Tract Therapy on the Phonation of Children With Vocal Fold Nodules

Dysphonia | Hoarseness | Voice Disorders in Children | Vocal Nodules in Children

Belgium
Jules Bordet Institute

Active, not recruiting

Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features

Head and Neck Cancer | Dysphagia

Belgium
Nestlé

Completed

Reduction of Aspiration Through Cohesive Thin Liquids (CTL) in Patients With Mild Oropharyngeal Dysphagia

Stroke | Dysphagia

Belgium, France
Pfizer

Completed

Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed Condition

Healthy Participants

Belgium
Centre d'Etudes et de Recherche pour l'Intensification...

Recruiting

Diabeloop For Teens (DBL4T)

Diabetes Mellitus, Type 1 | Closed Loop | Adolescents (12 to 17 Years Old)

Belgium, France, Germany
Lille Catholic University
Université Catholique de Louvain; Université de Lille 3

Completed

Developmental Language Difficulties: Behavioural and Electrophysiological Studies (LANGAGE)

Dyslexia | Dysphasia

Belgium, France
University Hospital of Mont-Godinne
Université Catholique de Louvain

Terminated

Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation (iSWAT)

Dysphagia | Acute Stroke

Belgium
PENTA Foundation
King's College Hospital NHS Trust; Karolinska Institutet; Hospital General Universitario... and other collaborators

Recruiting

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19 (SARS-Cov2)

Sars-Cov2 Antibodies in Children and Adolescents Living With HIV

Spain, United Kingdom, South Africa, Belgium, Greece, Ukraine
Pfizer

Completed

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Neurogenic Detrusor Overactivity

Belgium
University of Liege
Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire... and other collaborators

Recruiting

Development and Validation of the SWADOC Tool

Dysphagia | Swallowing Disorders | Disorders of Consciousness | Speech Therapy | Assessment Tool

France, Belgium
University Medical Center Nijmegen

Recruiting

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention (TUBA-WISP-II)

Ovarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene Mutation

Netherlands, United States, Belgium, Norway, Poland, Italy, Australia, Mexico, Brazil, Sweden, Uruguay
Pfizer

Terminated

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Locally Advanced or Metastatic Solid Tumors | Genes, BRCA 1

United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
QED Therapeutics, Inc.
Helsinn Healthcare SA

Terminated

A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma

FGFR2 Gene Mutation | Advanced Cholangiocarcinoma

United States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
Day One Biopharmaceuticals, Inc.

Recruiting

Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors

Melanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditions

United States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
QED Therapeutics, Inc.
Helsinn Healthcare SA

Terminated

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

FGFR2 Gene Mutation | Advanced Cholangiocarcinoma

Korea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
Taiho Oncology, Inc.

Active, not recruiting

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements (FOENIX-CCA3)

Advanced Cholangiocarcinoma | FGFR2 Gene Rearrangements

United States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
Bayer

Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

United States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
Pfizer
Medivation, Inc.

Completed

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA)

Breast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene Mutation

Korea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
Basilea Pharmaceutica

Completed

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (FIDES-01)

Intrahepatic Cholangiocarcinoma | Combined Hepatocellular and Cholangiocarcinoma

Canada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
Spectrum Pharmaceuticals, Inc

Terminated

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Diffuse Large B-cell Lymphoma | Follicle Center Lymphoma

United States, France, United Kingdom, Ireland, Israel, Belgium, Spain, Netherlands, Australia, Puerto Rico, Canada, Italy, Austria
Kura Oncology, Inc.

Active, not recruiting

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy (AIM-HN/SEQ-HN)

HNSCC | HRAS Gene Mutation

United States, Belgium, Spain, United Kingdom, Taiwan, Denmark, Korea, Republic of, Netherlands, Thailand, Germany, Malaysia, Austria, Italy, Greece, Australia, Norway
Tesaro, Inc.
European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaborators

Terminated

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

Ovarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of Breast

United States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
Pfizer

Terminated

A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)

Dilated Cardiomyopathy | Lamin A/C Gene Mutation

United States, Spain, Canada, Belgium, Italy, Argentina, Mexico, Netherlands, Norway, United Kingdom
Biogen

Recruiting

A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation (ATLAS)

Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation

United States, Canada, Spain, Australia, Germany, Italy, Japan, Korea, Republic of, United Kingdom, Belgium, Brazil, France, Poland, Sweden

Clinical Trials on Gender Dysphoria, Adolescent in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations